Tomoxiprole

This classification denotes a cyclooxygenase inhibitor with the molecular formula C21H20N2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier EZ948T2878, chemically known as 3-isopropyl-2-(p-methoxyphenyl)-3h-naphth(1,2-d)imidazole but generally known as tomoxiprole, which bears US NIH Compound Identifier 53454. European Medicines Agency schedules Tomoxiprole in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11187MIG. The term TOMOXIPROLE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 39, No. 5, 1985, List 25). TOMOXIPROLE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule tomoxiprole under HS 29339990 and SITC 51577. As of Q4 2014, TOMOXIPROLE remains the US FDA Preferred Term for this commodity. Tomoxiprole bears US NLM identifiers UMLS ID C0076824 and NCI Concept Code C66611. SMILES: O(C1CCC(C2[NH]C3C(N2)C(C(C)C)CC2C3CCCC2)CC1)C.